Amodiaquine and pyrimethamine/sulfadoxine

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51102900
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51102905

This is a combination therapy used for seasonal malaria chemoprevention. The first component, AMODIAQUINE, has a US FDA Unique Ingredient Identifier of 220236ED28. The second component, PYRIMETHAMINE, has a US FDA Unique Ingredient Identifier of Z3614QOX8W. The third component, SULFADOXINE, has a US FDA Unique Ingredient Identifier of 88463U4SM5.

Same parent

Under 51102900 · 11

51102901 Artemether/lumefantrine Commodity 51102902 Atovaquone/proguanil Commodity 51102903 Chloroquine/primaquine Commodity 51102904 Pyrimethamine/sulfadoxine Commodity 51102905 Amodiaquine and pyrimethamine/sulfadoxine You are here 51102906 Artenimol/piperaquine Commodity 51102907 Amodiaquine/artesunate Commodity 51102908 Artesunate/mefloquine Commodity 51102909 Artesunate/Pyronaridine Commodity 51102910 Dihydroartemisinin/Piperaquine Commodity 51102911 Artesunate/Pyronaridine Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51100000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.